Antibody and cytokine responses in kittens during the development of feline infectious peritonitis (FIP)

Veterinary Immunology and Immunopathology

Volumn 65, Issue 2-4, 1998, Pages 221-242

  Gunn Moore, D A ^a   Caney, S M A ^a   Gruffydd Jones, T J ^a   Helps, C R ^a   Harbour, D A ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Cytokine; Feline infectious peritonitis; Immune response

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; MESSENGER RNA; RECOMBINANT PROTEIN; VIRUS ANTIBODY; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; CAT; CAT DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; CORONAVIRUS; HUMORAL IMMUNITY; MONONUCLEAR CELL; NONHUMAN; VIRUS NEUTRALIZATION;

ANIMALS; ANTIBODIES, VIRAL; ANTIBODY FORMATION; CATS; CORONAVIRUS, FELINE; CYTOKINES; DNA PRIMERS; DNA PROBES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FELINE INFECTIOUS PERITONITIS; MEMBRANE GLYCOPROTEINS; NEUTRALIZATION TESTS; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPECIFIC PATHOGEN-FREE ORGANISMS; VIRAL ENVELOPE PROTEINS;

EID: 0032561278     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-2427(98)00156-1     Document Type: Conference Paper

References (82)

1. Al-Janadi M., Al-Balla S., Al-Dalaan A., Raziuddin S. Cytokine profile in systemic lupus erythematosus, rhumatoid arthritis and other rheumatic diseases. J. Clin. Immunol. 13:1993;58-67.
2. Argyle D.J., Smith K., McBride K., Fulton R., Onions D.E. Nucleotide and predicted peptide sequence of feline interferon-gamma (IFNγ). DNA Sequence. 5(3):1995;169-171.
3. Argyle, D.J., Hanlon, L., Onions, D.E., 1996. The cloning of feline specific TH1 cytokines and their potential in therapy and vaccination. Workshop on Cytokines in FIV and HIV infection, Pisa, Italy, pp. 14.
4. Ausubel, F.A., Brent, R., Kingston, R.E., Moore, D.D., Seidman, J,G., Smith, J.A., Struhl, K. (Eds.), 1995. Current Protocols in Molecular Biology. Wiley, New York.
5. Barlough J.E. Serodiagnostic aids and management practice for feline retrovirus and coronavirus infections. Vet. Clin. North Am. 14:1984;955-969.
6. Barlough, J.E., Stoddart, C.A., 1990. Feline coronavirus infections. In: Greene, C.E. (Ed.), Infectious diseases of the dog and cat. W.B. Saunders Company, Philadelphia, pp. 300-312.
7. Berger S., Ballo H., Jochen Stutte H. Immune complex-induced interleukin 6, interleukin 10 and prostaglandin secretion by human monocytes: a network of pro- and anti-inflammatory cytokines dependent on the antigen : antibody ratio. Eur. J. Immunol. 26:1996;1297-1301.
8. Berlinski, P., Lowery, D., Guimond, P., Wardley, R., 1996. Comparison of immunization against feline immunodeficiency virus using recombinant feline herpes virus and baculovirus. 3rd Int. Feline Retrovirus Research Symp., Fort Collins, USA, pp. 66.
9. Bradley W.G., Gibbs C., Kraus L., Good R.A., Day N.K. Molecular cloning and characterization of a cDNA encoding feline interleukin 6. Proc. Soc. Exp. Biol. 204:1993;301-305.
10. Brown C.S., Welling-Webster S., Feijlbrief M., Van Lent J.W., Spaan W.J. Chimeric parvovirus B19 capsids for the presentation of foreign epitopes. Virology. 198:1994;477-488.
11. Carvalho D., Savage C. Cytokines, adhesion molecules, anti-endothelial cell autoantibodies and vascular disease. Cardiovascular Path. 6(2):1997;61-78.
12. Chalmers W.S., Horsburgh B.C., Baxendale W., Brown T.D. Enhancement of FIP in cats immunised with vaccinia virus recombinants expressing CCV and TGEV spike glycoproteins. Adv. Exp. Med. Biol. 342:1993;359-364.
13. Clerici M., Shearer G.M. A TH1 to TH2 switch is a critical step in the aetiology of HIV infection. Immunol. Today. 14:1993;107-111.
14. Corapi W.V., Olsen C.W., Scott F.W. Monoclonal antibody analysis of neutralization and anti-body-dependent enhancement of feline infectious peritonitis virus. J. Virol. 66:1992;6695-6705.
15. Corapi W.V., Darteil R.J., Audonnet J.C., Chappuis G.E. Localisation of genetic sites of the S glycoprotein of feline infectious peritonitis virus involved in neutralisation and antibody-dependent enhancement. J. Virol. 69(5):1995;2858-2862.
16. Cozzi P.J., Padrid P.A., Takeda J., Alegre M.-L., Yuhki N., Leff A.R. Sequence and functional characterization of feline interleukin 2. Biochem. Biophy. Res. Commun. 194:1993;1038-1043.
17. Dean, G., Woo, J., LaVoy, A., Moore, P., Pedersen, N., 1997. Cytokine expression in feline lymphoid tissue in health and disease. Feline Immunology Workshop, Davis, USA, Abstract Number 2-2.
18. De Groote D., Zangerle P.F., Gevaert Y., Fassotte M.F., Beguin Y., Noizat-Pirenne F., Pirenne J., Gathy R., Lopez M., Dehart I., Igot D., Baudrihaye M., Delacroix D., Franchimont P. Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood I. Comparison with isolated PBMC stimulation. Cytokine. 4:1992;239-248.
19. + T-cells in vivo. Eur. J. Immun. 23:1993;1757-1761.
20. Flory E., Stuhler A., Barac-Latas V., Lassmann H., Wege H. Coronavirus-induced encephalomyelitis: balance between protection and immune pathology depends on the immunization schedule with spike protein S. J. Gen. Virol. 76:1995;873-879.
21. Gerber J.D., Ingersoll J.D., Gast A.M., Christianson K.K., Selzer N.L., Landon R.M., Pfeiffer N.E., Sharpee R.L., Beckenhauer W.H. Protection against feline infectious peritonitis by intranasal inoculation of a temperature-sensitive FIPV vaccine. Vaccine. 8:1990;536-542.
22. Goitsuka R., Hirota Y., Hasegawa A., Tomoda I. Feline interleukin 2 activity. Jpn. J. Vet. Sci. 48(3):1986;529-537.
23. Goitsuka, R., Hirota, Y., Hasegawa, A., Tomoda, I., 1987a. The decline in production of interleukin 2 in cats spontaneously infected with feline leukemia virus. Jpn. J. Vet. Sci. 49(1), 7-14.
24. Goitsuka, R., Hirota, Y., Hasegawa, A., Tomoda, I., 1987b. Release of interleukin 1 from peritoneal exudate cells of cats with feline infectious peritonitis. Jpn. J. Vet. Sci. 49(5), 811-818.
25. Goitsuka R., Onda C., Hirota Y., Hasegawa A., Tomoda I. Feline interleukin 1 production induced by feline infectious peritonitis. Jpn. J. Vet. Sci. 50(1):1988;209-214.
26. Goitsuka R., Ohashi T., Ono K., Hirota Y., Hasegawa K., Koishibara Y., Fukui H., Ohsugi Y., Hasegawa A. Interleukin 6 activity in feline infectious peritonitis. J. Immunol. 14:1990;2599-2603.
27. Goitsuka, R., Furusawa, S., Mizoguchi, M., Hasegawa, A., 1991a. Detection of interleukin 1 in ascites from cats with feline infectious peritonitis. J. Vet. Med. Sci. 53(3), 487-489.
28. Goitsuka, R., Tsuji, M., Ohashi, T., Onda, C., Tuchiya, K., Hirota, Y., Takahashi, E., Hasegawa, A., 1991b. Characterisation of a feline infectious peritonitis virus isolate. Jpn. J. Vet. Sci. 53(2) 337-339.
29. Gualandi G.L., Losio N.M., Muratori G., Foni E. The ability by different preparations of porcine parvovirus to enhance humoral immunity in swine and guinea pigs. Microbiologica. 11(4):1988;363-369.
30. Haagmans B.L., Egberink H.F., Horzinek M.C. Apoptosis and T-cell depletion during feline infecyious peritonitis. J. Virol. 70:1996;8977-8983.
31. Hagiwara E., Abbasi F., Mor G., Ishigatsubo Y., Klinman D.M. Phenotype and frequency of cells secreting IL-2, IL-4, IL-6, IL-10, IFN and TNFα in human periferal blood. Cytokine. 7(8):1995;815-822.
32. Harbour D.A., Howard P.E., Gaskell R.M. Isolation of feline calicivirus and feline herpesvirus from domestic cats 1980-1989. Vet. Rec. 128:1991;77-80.
33. Hasegawa T., Hasegawa A. Interleukin 1 alpha mRNA-expressing cells on the local inflammatory response in feline infectious peritonitis. Jpn. J. Vet. Sci. 53(6):1991;995-999.
34. Hayashi T., Goto N., Takahashi R., Fujiwara K. Systemic vascular lesions in feline infectious peritonitis. Jpn. J. Vet. Sci. 39:1977;365-377.
35. Hayashi T., Watabe Y., Nakayama H., Fujiwara K. Enteritis due to feline infectious peritonitis virus. Jpn. J. Vet. Sci. 44:1982;97-106.
36. Helle M., Brakenhoff J.P.J., De Groot E.R., Aarden L.A. Interleukin 6 is involved in interleukin 1-induced activities. Eur. J. Immunol. 18:1988;957-959.
37. Herrewegh A.A.P.M., Vennema H., Horzinek M.C., Rottier P.J.M., De Groot R.J. The molecular genetics of feline coronaviruses: comparative sequence analysis of the ORF7a/7b transcrition unit of different biotypes. Virology. 212:1995;622-631.
38. Hilkens C.M., Snijders A., Vermeulen H., Van Der Meide P.H., Wierenga E.A., Kapsenberg M.L. Accessory cell-derived IL-12 and prostaglandin E2 determine the IFN-gamma level of activated human CD4+ T-cells. J. Immunol. 156:1996;1722-1727.
39. Hohdatsu T., Nakamura M., Ishizuka Y., Yamada H., Koyama H. A study on the mechanism of antibody-dependent enhancement of feline infectious peritonitis virus infection in feline macrophages by monoclonal antibodies. Arch. Virol. 120:1991;207-217.
40. Jacobse-Geels H.E.L., Daha M.R., Horzinek M.C. Isolation and characterisation of feline C3 and evidence of the immune complex pathogenesis of feline infectious peritonitis. J. Immunol. 125:1980;1606-1610.
41. Jacobse-Geels H.E.L., Horzinek M.C. Expression of feline infectious peritonitis coronavirus antigens on the surface of feline macrophage-like cells. J. Gen. Virol. 64:1983;1859-1866.
42. Jirik F.R., Podor T.J., Hirano T., Kishimoto T., Loskutoff D.J., Carson D.A., Lotz M. Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human endothelial cells. J. Immunol. 142:1989;144-147.
43. Lin D.-S., Bowman D.D. Cellular responses of cats with primary toxoplasmosis. J. Parasitol. 77:1991;272-279.
44. Lutz H., Hofmann-Lehmann R., Bauer-Pham K., Holznagel E., Tozzini F., Bendinelli M., Reubel G., Aubert A., Davis D., Cox D., Young E. FIV vaccine studies I. Immune response to recombinant FIV env gene products and outcome after challenge infection. Vet. Immunol. Immunopathol. 46:1995;103-113.
45. Maeda K., Ono M., Kawaguchi Y., Niikura M., Okazaki K., Yokoyama N., Tokiyoshi Y., Tohya Y., Mikami T. Expression and properties of feline herpesvirus type 1 gD (hemagglutinin) by a recombinant baculovirus. Virus Res. 46:1996;75-80.
46. Maggi E., Macchia D., Parronchi P., Mazzetti M., Ravina A., Milo D., Romagnani S. Reduced production of interleukin 2 and interferon-gamma and enhanced helper activity for IgG synthesis by cloned CD4+ T-cells from patients with AIDS. Eur. J. Immunol. 17:1987;1685-1690.
47. Mosmann T.R., Coffman R.L. Heterogeneity of cytokine secretion patterns and functions of helper T-cells. Adv. Immunol. 46:1986;111-147.
48. Mumford J.A., Wilson H., Hannant D., Jessett D.M. Antigenicity and immunogenicity of equine influenza vaccines containing a Carbomer adjuvant. Epidemiol. Infection. 112(20):1994;421-437.
49. Ohashi T., Matsumoto Y., Watari T., Goitsuka R., Tsujimoto H., Hasegawa A. Molecular cloning of feline interleukin 6 cDNA. J. Vet. Med. Sci. 55(6):1993;941-944.
50. Olsen C.W., Corapi W.V., Ngichabe C.K., Baines J.D., Scott F.W. Monoclonal antibodies to the spike protein of feline infectious peritonitis virus mediate antibody-dependent enhancement of infection of feline macrophages. J. Virol. 66(2):1992;956-965.
51. Olsen C.W., Corapi W.V., Jacobson R.H., Simkins R.A., Saif L.J., Scott F.W. Identification of antigenic sites mediating antibody-dependent enhancement of feline infectious peritonitis virus infectivity. J. Gen. Virol. 74:1993;745-749.
52. Pedersen, N.C., Black, J.W., 1983. Attempted immunization of cats against feline infectious peritonitis, using avirulent live virus or sublethal amounts of virulent virus. Am. J. Vet. Res. 44, 229-234.
53. Pedersen, N.C., 1987. Virologic and immunologic aspects of feline infectious peritonitis virus infection. Adv. Exp. Med. Biol., 218, 529-550.
54. Pedersen N.C. An overview of feline enteric coronavirus and infectious peritonitis virus infections. Feline Practice. 23(3):1995;7-19.
55. Pedersen, N.C., Floyd, K., 1985. Experimental studies with three new strains of feline infectious peritonitis virus: FIPV-UCD2, FIPV-UCD3, and FIPV-UCD4. Compendium for Continuing Education for the Practicing Vetenarian. 7, 1001-1011.
56. Pedersen N.C., Black J.W., Boyle J.F., Evermann J.F., McKeirnan A.J., Ott R.L. Pathogenic differences between various feline coronavirus isolates. Adv. Exp. Med. Biol. 173:1984;365-380.
57. Rincon M., Anguita J., Nakamura T., Fikrig E., Flavell R.A. Interleukin (IL) 6 directs the differentiation of IL-4-producing CD4+ T-cells. J. Exp. Med. 185:1997;461-469.
58. Romagnani S. The Th1/Th2 paradigm. Immunol. Today. 18:1997;263-266.
59. Rottman J.B., Freeman E.B., Tonkonogy S., Tompkins M.B. A reverse transcription-polymerase chain reaction technique to detect feline cytokine genes. Vet. Immunol. Immunopathol. 45:1995;1-18.
60. Rottman J.B., Tompkins W.A.F., Tompkins M.B. A reverse transcription-quantitative competitive polymerase chain reaction (RT-qcPCR) technique to measure cytokine gene expression in domestic animals. Vet. Pathol. 33:1996;242-248.
61. Sakurai T., Ueda Y., Sato M., Yanai A. Feline interferon production in silkworm by recombinant baculovirus. J. Vet. Med. Sci. 54(3):1992;563-565.
62. Schijns, V.E.C.J., Wierda, C.M.H., Vahlenkamp, T.W., Horzinek, M.C., De Groot, R.J., 1995a. Molecular cloning and expression of cat interferon-γ. Immunogenetics 42, 440-441.
63. Schijns, V.E.C.J., Wierda, C.M.H., Van Dam, E.J.M., Vahlenkamp, T.W., Horzinek, M.C., 1995b. Molecular cloning of cat interleukin 4. Immunogenetics 42, 434-435.
64. Schultz R.D., Adams L.S. Immunologic methods for the detection of humoral and cellular immunity. Vet. Clin. North Am. 8:1978;721-768.
65. Scott F.W., Corapi W.V., Olsen C.W. Evaluation of the safety and efficacy of Primucell-FIPTM vaccine. Feline Health Top. 7:1992;6-8.
66. Scott, F.W., Corapi, W.V., Olsen, C.W., 1995a. Independent evaluation of a modified live FIPV vaccine under experimental conditions (Cornell experience). Feline Practice 23 (3), 74-76.
67. Scott, F.W., Olsen, C.W., Corapi, W.V., 1995b. Antibody-dependent enhancement of feline infectious peritonitis virus infection. Feline Practice 23 (3), 77-80.
68. Sironi M., Breviario F., Proserpio P., Biondi A., Vecchi A., Van Damme J., Dejana E., Mantovani A. IL-1 stimulates IL-6 production in endothelial cells. J. Immunol. 142:1989;549-553.
69. Spaan W., Cavanaugh D., Horzinek M.C. Coronaviruses: structure and genomic expression. J. Gen. Virol. 69:1988;2939-2952.
70. Sparkes A.H., Gruffydd-Jones T.J., Harbour D.A. Feline infectious peritonitis: a review of clinico-pathological changes in 65 cases, and a critical assessment of their diagnostic value. Vet. Rec. 129:1991;209-212.
71. Stoddart, M.E., 1985. Some studies on the pathogenesis of feline infectious peritonitis. Ph.D. Thesis, University of Bristol.
72. Stoddart M.E., Gaskell R.M., Harbour D.A., Gaskell C.J. Virus shedding and immune response in cats inoculated with cell culture-adapted feline infectious peritonitis virus. Vet. Microbiol. 16:1988;145-158.
73. Van der Pouw Kraan T.C., Boeije L.C., Smeenk R.J., Wijdenes J., Aarden L.A. Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production. J. Exp. Med. 181:1995;775-779.
74. Vennema H., De Groot R.J., Harbour D.A., Dalderup M., Gruffydd-Jones T.J., Horzinek M.C., Spaan W.J.M. Early death after feline infectious peritonitis virus challenge due to recombinant vaccinia virus immunisation. J. Virol. 64:1990;1407-1409.
75. Vennema H., Poland A., Floyd Hawkins K., Pedersen N. A comparison of the genomes of FECVs and FIPVs and what they tell us about the relationships between feline coronaviruses and their evolution. Feline Practice. 23(3):1995;40-44.
76. Voller, A., Bidwell, D.E., Bartlett, 1982. ELISA Techniques in Virology. In: New Developements in Practical Virology. Laboratory and Research Methods in Biology and Medicine, Volume 5. Editor C.R. Howard. Published by Alan R. Liss, Inc., New York, pp. 59-81.
77. Weiss, R.C., Scott, F.W., 1981a. Pathogenesis of feline infectious peritonitis: nature and developement of viraemia. Am. J. Vet. Res. 42, 382-390.
78. Weiss, R.C., Scott, F.W., 1981b. Pathogenesis of feline infectious peritonitis: pathogenic changes and immunofluorescence. Am. J. Vet. Res. 42, 2036-2048.
79. Weiss R.C., Scott F.W. Antibody-mediated enhancement of disease in feline infectious peritonitis: comparisons with dengue haemorragic fever. Compendium Immunol. Microbiol. Infect. Dis. 4:1981;175-189.
80. Weiss R.C., Vaughn D.M., Cox N.R. Increased plasma levels of leukotriene B4 and prostaglandin E2 in cats experimentally inoculated with feline infectious peritonitis virus. Vet. Res. Commun. 12:1988;313-323.
81. Woods R.D., Pedersen N.C. Cross-protection studies between feline infectious peritonitis and porcine transmissible gastroenteritis viruses. Vet. Microbiol. 4:1979;11-16.
82. Zhou Y., Lin G., Baarsch M.J., Scamurra R.W., Murtaugh M.P. Interleukin 4 suppresses inflammatory cytokine gene transcription in porcine macrophages. J. Leukemia Biol. 56:1994;507-513.